C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissueThe adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cellsComparison of inpatient and outpatient upper gastrointestinal haemorrhageNonsteroidal anti-inflammatory drugs versus selective COX-2 inhibitors in the upper gastrointestinal tractCharacterization of the human zinc finger protein 267 promoter: essential role of nuclear factor YZinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinomaSynovial density of frizzled 5-positive cells does not differ between patients with RA and OA and is independent of inflammationOX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in miceIn situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.Intensive care unit alarms—How many do we need?*Evaluation of differentially expressed genes by a combination of cDNA array and RAP-PCR using the AtlasImage 2.0 software.Magnetic resonance imaging gastrography: evaluation of the dark lumen technique compared with conventional gastroscopy in patients with malignant gastric disease.Morphological and molecular investigations of Tubulinosema ratisbonensis gen. nov., sp. nov. (Microsporidia: Tubulinosematidae fam. nov.), a parasite infecting a laboratory colony of Drosophila melanogaster (Diptera: Drosophilidae).Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report.Transfer of the members of the genus Brachiola (microsporidia) to the genus Anncaliia based on ultrastructural and molecular data.A case of Waldenstroem's disease with a monoclonal IgM antiphospholipid antibody.Risk factors for negative blood cultures in adult medical inpatients--a retrospective analysis.Collection of annotated data in a clinical validation study for alarm algorithms in intensive care--a methodologic framework.Frequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD).A patient with Pfeifer-Weber-Christian disease--successful therapy with cyclosporin A: case report.Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and strictures.Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis.Association of Crohn's disease and latent celiac disease: a case report and review of the literature.Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors.Clinical determinants for the recovery of fungal and mezlocillin-resistant pathogens from bile specimens.Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes.Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetesActivated hepatic stellate cells express keratinocyte growth factor in chronic liver diseaseBCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells.New developments in aetiological mechanisms of inflammatory bowel disease.The multiple facets of premature aging in rheumatoid arthritis.Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.Biological therapy in IBD. Anti-tumor necrosis factor-alpha and others.Doppler ultrasound and intravenous contrast agents in gastrointestinal tract disorders: current role and future implications.
P50
Q24297445-591AEDBC-4B23-4DB6-9451-AF631AAA015BQ24337848-123C016E-D7A3-4FE5-A04C-C66E0598F018Q28210405-BB461AB8-FC00-4633-A5A0-1CBBF7C06DC9Q28219324-16F99A30-1BFE-49A1-BD4A-320937362ABBQ28243787-A4725360-E096-4894-8992-848A91753A20Q28264611-B87587DC-0A9D-4021-8BDA-865D7962B3CBQ28265788-7F3E03B4-4D57-4B0F-BD7D-407AFDD3CD01Q28279812-9D2AC2B2-C18B-4C6F-95B2-24FBE3BCF6CFQ28504540-896B5A43-8DA7-408F-9D87-213ABEB31327Q30350400-D44E0158-4D92-4406-A58A-8217230DAECEQ30464700-250DC115-8D5E-4585-BF0B-7B32C989757DQ30978137-C19F4862-A709-44C3-B619-8C5CA20E84A3Q30982900-60E0D281-1EF8-478B-8727-78831D2F098AQ30986721-4E3AED63-FA28-4151-B847-BECC8A52D242Q30987023-79E0AD49-1545-41F6-8024-577900C6035FQ31030847-359D6C06-E3D1-46F3-8776-2DBB2971D412Q33343157-DFED13A4-A0F8-4FF9-BE8D-C4F8B189EEA3Q33379958-221506D5-8B1A-4B81-90A3-39B63C0A4DEFQ33423281-189BC1EB-85F0-4E9A-8C07-87101A2494A5Q33425208-BA603C9A-2D41-446C-A03B-CC7796625495Q33526876-4EBA08EB-50DC-437D-9464-D107BE11F90DQ33541428-B363B7AC-26AC-493F-9DEE-5DE64AD3760AQ33694536-4AA1E096-21D8-45CB-870E-E192ED64CBFBQ33951214-910E5C98-4B7D-491B-9470-060D5ED17817Q33972858-ECA78CE9-C52D-44A1-A195-DEFF498B3177Q34091040-9F903F73-AA7E-41AC-A548-EF22A35F9B4EQ34312555-171DC8A9-6602-4100-B7FB-D60242AA9564Q34373271-6EFD54FF-6656-40A7-BEBE-04F3B5433D46Q34434495-222B2875-FD63-4FA3-9F2E-363FFE44CF0FQ34553503-241E6711-6699-46CE-8849-528442C33A12Q34656848-5E3FAEDF-8444-4652-961E-16413AB116EFQ34880667-8F305F62-789E-490F-A514-42A6BACF692EQ35024550-BE2A0D6A-92BC-465F-8881-1052CF5C2131Q35103291-BC180184-C7E0-4639-B4B0-F72E3C0752D9Q35128196-F76F0AD2-B5EC-4756-B021-551293871AEFQ35168832-8E487912-00C3-47DD-A44C-F387F03D468FQ35559238-E0976E71-D780-4BFF-9895-BC6142A4D012Q35565051-AA54E823-89AA-44BC-A884-E146E9367F97Q35565071-BC40AD26-EEF7-4AFF-9B04-76A711733D22Q36044959-3A646695-F935-4F37-AE42-868DAAFFF338
P50
description
Duits internist
@nl
German internist
@en
deutscher Internist und Hochschullehrer
@de
dochtúir Gearmánach
@ga
professor académico alemão
@pt
tysk professor
@da
tysk professor
@sv
name
Jürgen Schölmerich
@ast
Jürgen Schölmerich
@ca
Jürgen Schölmerich
@da
Jürgen Schölmerich
@de
Jürgen Schölmerich
@en
Jürgen Schölmerich
@es
Jürgen Schölmerich
@fr
Jürgen Schölmerich
@nb
Jürgen Schölmerich
@nds
Jürgen Schölmerich
@nl
type
label
Jürgen Schölmerich
@ast
Jürgen Schölmerich
@ca
Jürgen Schölmerich
@da
Jürgen Schölmerich
@de
Jürgen Schölmerich
@en
Jürgen Schölmerich
@es
Jürgen Schölmerich
@fr
Jürgen Schölmerich
@nb
Jürgen Schölmerich
@nds
Jürgen Schölmerich
@nl
altLabel
Jurgen Scholmerich
@nl
Schölmerich
@de
prefLabel
Jürgen Schölmerich
@ast
Jürgen Schölmerich
@ca
Jürgen Schölmerich
@da
Jürgen Schölmerich
@de
Jürgen Schölmerich
@en
Jürgen Schölmerich
@es
Jürgen Schölmerich
@fr
Jürgen Schölmerich
@nb
Jürgen Schölmerich
@nds
Jürgen Schölmerich
@nl
P1006
P214
P227
P244
P269
P1006
P1412
P1559
Jürgen Schölmerich
@de
P19
P21
P213
0000 0000 9586 1671